Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Daily News

PREVENT Tool Accurately Predicts HF Risk, With ‘Strong’ ASCVD Overlap

Yael L. Maxwell

December 17, 2024

News Daily News

Young Men Who Take Steroids Have Impaired Coronary Flow, Even After Quitting

Caitlin E. Cox

December 17, 2024

News Daily News

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

L.A. McKeown

December 13, 2024

News Conference News TCT 2024

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Todd Neale

October 28, 2024

Presentation TCT 2024

TCT 190: Exploring the Effectiveness of Transfer Learning in Identifying Left Ventricular Systolic Dysfunction Among Patients With Left Bundle Branch Block

Presenter: Hak Seung Lee

October 27, 2024

News Conference News HFSA 2024

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

L.A. McKeown

October 04, 2024

News Conference News HFSA 2024

‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF

Michael O'Riordan

October 03, 2024

News Conference News HFSA 2024

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

Michael O'Riordan

October 02, 2024

News Conference News ESC 2024

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

Michael O'Riordan

August 30, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Conference News NY Valves 2024

Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR

Michael O'Riordan

June 10, 2024

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Conference News ESC Heart Failure 2024

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Michael O'Riordan

May 13, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

Presentation THT Abstracts 2024

Investigating the Efficacy of Transfer Learning for the Detection of Left Ventricular Systolic Dysfunction in Left Bundle Branch Block Patients: An Experimental Approach †

Presenter: Kyung-Hee Kim

March 04, 2024

Presentation THT 2024

Investigating the Efficacy of Transfer Learning for the Detection of Left Ventricular Systolic Dysfunction in Left Bundle Branch Block Patients: An Experimental Approach

Presenter: Kyung-Hee Kim

March 04, 2024

News Daily News

CRT-D Offers Persistent Survival Benefit in Long-term RAFT Results

Todd Neale

January 23, 2024

News Daily News

Most Takotsubo Patients Die From CV Causes, but Standard Meds No Help

Todd Neale

January 11, 2024

Advertisement

PREVENT Tool Accurately Predicts HF Risk, With ‘Strong’ ASCVD Overlap

Young Men Who Take Steroids Have Impaired Coronary Flow, Even After Quitting

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

TCT 190: Exploring the Effectiveness of Transfer Learning in Identifying Left Ventricular Systolic Dysfunction Among Patients With Left Bundle Branch Block

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

August 2024 Dispatch for the CV Team

Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR

June 2024 Dispatch for the CV Team

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

May 2024 Dispatch for the CV Team

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Investigating the Efficacy of Transfer Learning for the Detection of Left Ventricular Systolic Dysfunction in Left Bundle Branch Block Patients: An Experimental Approach †

Investigating the Efficacy of Transfer Learning for the Detection of Left Ventricular Systolic Dysfunction in Left Bundle Branch Block Patients: An Experimental Approach

CRT-D Offers Persistent Survival Benefit in Long-term RAFT Results

Most Takotsubo Patients Die From CV Causes, but Standard Meds No Help

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content